Medihelp denies funding for child with Hunter Syndrome

Original Article by Amanda Visser | Moneyweb | 4 July 2025

The CMS appeals committee ruled Medihelp can deny Elaprase therapy for a young Hunter syndrome patient, citing solvency over PMB obligations.

The CMS appeals committee ruled Medihelp can deny Elaprase therapy for a young Hunter syndrome patient, citing solvency over PMB obligations.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here